全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Is ‘GOLD’ standard for the management of COPD in clinical practice?

DOI: 10.7573/dic.212243

Keywords: chronic bronchitis , COPD , emphysema , exacerbations , FEV1 , formoterol , FVC , GOLD , immunization , indacaterol , LABA , LAMA , LTRA , methylxanthines , respimat , roflumilast , SGRQ , tiotropium , TORCH , UPLIFT

Full-Text   Cite this paper   Add to My Lib

Abstract:

Summary: primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations. COPD is a systemic disease and often requires therapy of its protean-associated morbidities from depression to osteoporosis and muscle wasting. Despite pessimism from some, COPD is treatable.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413